Release Date: 05/08/11 09:49 Summary: Reports Second Quarter 2011 Revenues of US$20.4 Million Price Sensitive: Yes Download Document 256.64KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status